Skip to main content

Welcome to the CRL Insurer Services blog. From big data and insurtech to accelerated underwriting and self-service products, the world of life insurance is moving at an unprecedented pace. We are confident that mortality data and insurance industry capabilities will continue to evolve, and seek to provide relevant expertise and updates to our valued clients.

As we continue to provide lab, data, and underwriting services through the CRL Insurers Business Unit, we look forward to sharing updates with you here. Check out the latest posts below from our dedicated team of medical directors and industry leaders, who provide commentary on timely topics, innovative services and solutions, and the existing database of CRL expertise.

 

Recent Publication on Mortality: Impacts on Insurers

June 28, 2021

Recently Dr. Michael Fulks commented on 2020 mortality data from JAMA, citing an increase of 17.7% from 2019 to 2020… Read More

Tags: Cancer, Insurance, Life Insurance, Mortality, Retirement

2020 US Mortality Results: How do they compare to prior years?

June 17, 2021

Dr. Michael Fulks, Consulting Medical Director to CRL, comments on the 2020 leading causes of death in a COVID-19 world…. Read More

Tags: Cancer, Covid 19, Heart Disease, Life Insurance, Mortality

Globulin: A Warning Underwriters Cannot Ignore

July 14, 2020

How do you find a very expensive early mortality risk, most of which is the result of undiagnosed — but… Read More

Tags: Cancer, Lab Tests, Life Insurance, Mortality, Underwriting

The Mortality Association of CEA in an Insurance Population

June 9, 2020

In a recent Journal of Insurance Medicine article¹, Drs. Rigatti and Stout used data from over 300,000 individuals who had… Read More

Tags: Cancer, Doctors, Life Insurance, Mortality, Underwriting

PSA Values & Mortality Risk: Coverage Considerations

June 2, 2020

What to do about an elevated PSA value that is newly found on insurance screening or under “active surveillance”? We… Read More

Tags: Cancer, Life Insurance, Mortality, Prostate, Underwriting